Navigation Links
North American Insurance Leaders, Inc. Announces Results of the Annual Meeting of Stockholders
Date:3/25/2008

NEW YORK, March 25 /PRNewswire-FirstCall/ -- North American Insurance Leaders, Inc. (Amex: NAO), today announced that the holders of a majority of the common stock of NAO entitled to vote at the annual meeting of stockholders held today voted against the proposal to consummate a business combination, as presented in the NAO proxy statement dated January 31, 2008.

Since NAO will not be able to complete its proposed acquisition of the insurance businesses of Deep South Holding, L.P., the NAO Board of Directors is now considering alternatives that may be in the best interests of the NAO stockholders, including the adoption of a plan of dissolution and liquidation in accordance with applicable provisions of Delaware law.

About North American Insurance Leaders, Inc.

North American Insurance Leaders, Inc. is a special purpose acquisition corporation focused on acquiring businesses in the insurance or insurance related industry. NAO raised net proceeds of approximately $110 million through its initial public offering in March 2006. On August 10, 2007, NAO announced the signing of a definitive agreement to acquire the insurance businesses of Deep South Holding, L.P.


'/>"/>
SOURCE North American Insurance Leaders, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. North American Insurance Leaders, Inc. Receives an Estimate of Deep South 2007 Governing EBITDA
2. Evanston-Northwestern Study Proves Effectiveness of MRSA Screening to Reduce Hospital Infections
3. In Northern California Bald Women Get Their Heads Together
4. Cardiac Science to Present at the Seventh Annual Invest Northwest Conference
5. Northwestern Memorial Hospital, CAPS, and p4ps Host Consumer Forum to Advance Partnerships to Improve Healthcare Patient Safety
6. Accurays CyberKnife System Receives 2008 North American Medical Devices Product of the Year Award From Frost & Sullivan
7. California Small Business Association Condemns California Nurses Associations Decision to Call Prolonged Strike at Hospitals Throughout Northern California
8. Northwestern Mutual Is Americas Most Admired for an Unprecedented 25th Year
9. UT Southwestern surgeons complete North Texas first single-incision gallbladder removal
10. 5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain
11. Lauren Debrauwere Released from Northwestern Memorial Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...Newswire-USNewswire/ -- The Pew Charitable Trusts ...director, chemical and food safety programs, in it...n, who was formerly deputy staff director and gene... and Public Works, brings nearly 25 years of exper...y to Pew. , , "We are excited to be joined by ...
(Date:1/8/2009)...RNewswire-FirstCall/ -- Cephalon, Inc . (Nasdaq: ...Ph.D., Chairman and CEO will present at the J.P. ...y 13, 2009 in San Francisco, CA at approximately 4...resentation will be webcast live on the investor r... The webcast will be archived for one week followi...
(Date:1/8/2009)...8 Heska Corporation (Nas... , , What: Heska Corporation Invites You...r-End 2008 Earnings Conference Call on the Web,...MST], Where: www.heska.com (click on the ...link on the front page of this website)., Ho...
(Date:1/8/2009)...n. 8 St. Jude Children,s Research,...d that FedExCup Runner-Up,Camilo Villegas has inc...a,pledge to match Singh,s donation of $5,000 to S...TOUR. Eagles for St. Jude is a powerful program t...Singh and rising LPGA star Morgan,Pressel, along ...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...y conducted by the Mayo Clinic has revealed that a... Fibromyalgia is a disorder considered disabling ...ad musculoskeletal pain and symptoms such as fatig...ep disturbance. No cure is known and available tre...
...y has shown that reality was different from severa...pular misconception among both the young// and the...ccur when they're young in spite of research havin...equated with unhappiness for other people, individ...
...the study conducted by the Public Service Commissi...er of public servants believe HIV/AIDS is curable/... ere surveyed fall in to the category of very high...ey are measured on a scale from one to five, with ...
...the Malaysian Health Minister Chua Soi Lek the peo...sary. Hence he requested the people to cut down// ...tyle. According to the statistics Malaysians on an...veryday. This is extremely high as the health off...
Other Medicine News:Health News:Acupuncture to Relieve Fibromyalgia Symptoms 2Health News:Attitudes About Aging Different from Reality 2Health News:Attitudes About Aging Different from Reality 3
(Date:1/5/2009)...e/ -- Cylene Pharmaceuticals announced today that ...ral CK2 protein kinase inhibitor, CX-4945, in pati...se, or multiple myeloma. The primary endpoints of ...f safety, tolerance and PK properties of CX-4945 a...als. In addition, multiple mechanism-related pharm...
(Date:12/30/2008)...ire-USNewswire/ -- The Coalition for 21st Century ...ed by Genentech, Inc. on December 5, 2008, seeking...diagnostic tests to physicians and patients. The ...would harm patient care and rests on flawed scient...ssion is to encourage the research, development, a...
(Date:12/27/2008)...-year silence, offers to ease cloning costs for Cl...S, Dec. 27 Six years to...oned child, Dr. Brigitte Boisselier, head of the c...d other babies cloned by her company are growing u...eir families, privacy. , , "We,ve helped almost...
(Date:12/17/2008)...wswire/ -- PEAK Surgical, Inc., a medical,device ... system based on a,proprietary technology, announ...ion (FDA) has granted the company 510(k) clearance... and coagulation of soft tissue during,plastic an...cologic,orthopedic, arthroscopic, spinal and neu...
Breaking Medicine Technology:Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 2Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 3Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients 4'We're Ready to Prove It!' 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Breckenridge Pharmaceutical Enters Agreement With Helm AG 28Hamburg Germany 29 to Develop Additional ANDA Project 15702 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 1CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 2CV Therapeutics Anti Ischemic Therapy Ranexa 28R 29 Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN TIMI 36 Patient 1666 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 1mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 2mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 3mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 4mtvU Unleashes Month OF Exclusive Album Leaks 26 Music Video Premieres in Continued Fight Against Darfur Genocide 15697 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 1Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 2Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 3Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 4Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 5Final Data From the Bioheart Seismic Trial Suggest Safety Efficacy of Autologous Stem Cell Therapy for Treating Congestive Heart Failure 1664 6
...SS WIRE)--Mar 26, 2007 - A study comparing,the for...lazine,(HYD) used in V-HeFT I and V-HeFT II, and B... in the African American Heart Failure,Trial (A-He...ence,in the formulations used may explain why V-He...n decreasing mortality. Using,identical amounts of...
...already being treated with maximally,tolerated lip...ctions in LDL-C with similar reductions in other a...12, NEW ORLEANS, and CARLSBAD, Calif., March 26, 2..., Inc. announced,results from its ongoing Phase 2 ...ozygous familial hypercholesterolemia (HoFH),pres...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: